Related Experiment Videos
Intrahepatic cholestasis in childhood
The New England Journal of Medicine
|October 7, 1976
Summary
Neonatal cholestasis in children can lead to chronic liver disease, but many survive with normal lives. Early hepatitis may cause progressive bile duct hypoplasia and fibrosis.
Area of Science:
- Pediatric Gastroenterology
- Hepatology
- Neonatal Medicine
Background:
- Neonatal cholestasis is a critical condition requiring thorough investigation.
- The long-term outcomes for infants with neonatal cholestasis are not fully understood.
- Some children with neonatal obstructive jaundice appear to recover well, prompting further study.
Purpose of the Study:
- To investigate the clinical course, histologic features, and potential causes of neonatal cholestasis.
- To understand the long-term prognosis for children diagnosed with cholestasis in the neonatal period.
- To identify the progression of liver disease in affected children.
Main Methods:
- A cohort of 17 children with neonatal cholestasis was followed for 5 months to 22 years.
- Serial hepatic biopsies were performed on 11 children to assess liver histology.
- Clinical data, including survival and quality of life, were collected and analyzed.
Main Results:
- All children exhibited signs of chronic cholestasis, but most lived remarkably normal lives.
- Four children died, two from non-hepatic causes.
- Hepatic biopsies revealed progressive intrahepatic bile duct hypoplasia, portal fibrosis, and cirrhosis.
Conclusions:
- Neonatal cholestasis, potentially caused by perinatal hepatitis, can lead to progressive liver disease.
- Histologic changes suggest a single process from cholestasis to bile duct obliteration.
- Despite chronic cholestasis, many children achieve a good long-term quality of life.